Biotechnology Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR(TM) T Cell Product Candidate, for the Treatment of Multiple Myeloma April 27, 2022
Biotechnology GBT to Announce First Quarter 2022 Financial Results on Wednesday, May 4, 2022 April 27, 2022
Biotechnology Editas Medicine to Host Conference Call Discussing First Quarter 2022 Results and Corporate Update April 27, 2022
Biotechnology Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board April 26, 2022
Biotechnology Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? April 26, 2022
Biotechnology Editas Medicine Receives FDA Rare Pediatric Disease Designation for EDIT-301 for the Treatment of Beta Thalassemia April 26, 2022
Biotechnology Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl) April 26, 2022
Biotechnology Here’s How Much You’d Have If You Invested $1000 in Exelixis a Decade Ago April 26, 2022
Search
Biotechnology
